Aleksandr Levin
Papers
1
Total Citations
20
H-Index
1
About
Dr. Aleksandr Levin is a pioneering researcher at the forefront of bioprinting and regenerative medicine, with a focused expertise in *in situ* bioprinting technologies. His major contribution lies in advancing the clinical translation of bioprinting by developing the first commercial articulated collaborative *in situ* 3D bioprinter for skin wound healing. This breakthrough addresses a critical bottleneck in the field: while *in situ* bioprinting offers unparalleled clinical relevance by enabling direct tissue fabrication on the human body in an operating room—eliminating the need for post-printing bioreactors—no commercial system existed to support its widespread adoption. Levin’s work bridges this gap, providing a practical, collaborative robotic platform that can operate safely alongside surgeons. His landmark 2023 paper on this system has already garnered 20 citations, underscoring its immediate impact. By solving the engineering and clinical challenges of delivering bioprinted constructs directly onto wounds, Dr. Levin is paving the way for faster, more effective skin regeneration therapies, positioning himself as a key innovator in translating bioprinting from the lab bench to the bedside.
Research Focus
Key Achievements
Top Papers
- 1